Similar Search Results

Mothers as Insurance : Family Spillovers in WIC

Bitler, Marianne; Currie, Janet M.; Hoynes, Hilary W.; … - National Bureau of Economic Research - 2022

The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) is a widely used program. Previous research shows that WIC improves birth outcomes, but evidence about impacts on children and families is limited. We use a regression discontinuity leveraging an age five when...

Persistent link: https://www.econbiz.de/10013334331

Regulatory Incentives for Innovation : The FDA's Breakthrough Therapy Designation

Chandra, Amitabh; Kao, Jennifer L.; Miller, Kathleen L.; … - National Bureau of Economic Research - 2022

Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if a regulator can use new policy to innovate around this...

Persistent link: https://www.econbiz.de/10013477204

Evaluating the US Pharmaceutical Patent Policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2022

of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the … of new drug development, generic entry, and patent length and scope. Optimal policy calls for shorter but broader …

Persistent link: https://www.econbiz.de/10013309494

Give me your best shot! : diffusion of complete versus booster Covid-19 vaccines across US counties

Goel, Rajeev K.; Nelson, Michael A. - 2023

This paper compares drivers of full COVID-19 vaccinations and booster doses across U.S. counties. Booster doses are contingent upon someone receiving the primary doses, and the risk attitudes and propensities to get vaccinated may be different across individuals, along with the supply chain...

Persistent link: https://www.econbiz.de/10014313479

Consequences of a Shortage and Rationing : Evidence from a Pediatric Vaccine

Liebman, Eli; Lawler, Emily C.; Dunn, Abe; Ridley, David B. - National Bureau of Economic Research - 2023

Shortages and rationing are common in health care, yet we know little about the consequences. We examine an 18-month shortage of the pediatric Haemophilus Influenzae Type B (Hib) vaccine. Using insurance claims data and variation in shortage exposure across birth cohorts, we find that the...

Persistent link: https://www.econbiz.de/10014322866

Cancer Drug Prices in the US : Efficacy, Innovation, Clinical Trial Evidence, and Epidemiology

Michaeli, Daniel T.; Michaeli, Thomas - 2023

Background: Rising cancer drug prices pose a challenge for patients and healthcare systems in the US. Whilst prices are … routinely assigned to a drug’s original indication receiving US Food and Drug Administration (FDA) approval, the influence of … drug prices, distinctly analyzing original and supplemental indications.Data and Methods: Clinical trial evidence …

Persistent link: https://www.econbiz.de/10014357763

U.S. Senate Testimony on the Dept. Of Commerce OECD Drug Pricing Report

Outterson, Kevin - 2005

The US government has embarked on a trade strategy to address alleged free riding by raising patented prescription drug … to sign a bilateral trade agreement with the US. Increasing drug prices in these countries will greatly damage health …, given relatively high demand elasticities for pharmaceuticals in these populations; modest cash resources for health care …

Persistent link: https://www.econbiz.de/10014065505

Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development

Glennerster, Rachel; Kelly, Thomas; McMahon, Claire T.; … - National Bureau of Economic Research - 2024

A booster of the COVID-19 vaccine targeting the prevailing Omicron variant did not become available in the United States until a year after the variant was first detected. This pattern of developing, testing, and distributing a variant-specific booster may become the default response to further...

Persistent link: https://www.econbiz.de/10014468259

Investigator Racial Diversity and Clinical Trial Participation

Alsan, Marcella; Campbell, Romaine A.; Leister, Lukas; … - National Bureau of Economic Research - 2023

We investigate whether increased racial diversity of clinical trial principal investigators could increase the enrollment of Black patients, which currently lags population and disease-burden shares. We conducted a survey experiment in which respondents were shown a photo of a current NIH...

Persistent link: https://www.econbiz.de/10014372489

Fertility and Labor Market Responses to Reductions in Mortality

Bhalotra, Sonia R.; Venkataramani, Atheendar S.; … - National Bureau of Economic Research - 2022

We investigate women's fertility, labor and marriage market responses to a health innovation that led to reductions in mortality from treatable causes, and especially large declines in child mortality. We find delayed childbearing, with lower intensive and extensive margin fertility, a decline...

Persistent link: https://www.econbiz.de/10013361971